Glaxo Seeks Ban on Ranbaxy's Herpes Drug
Pharmaceutical giant GlaxoSmithKline wants a preliminary injunction banning generic drug manufacturer Ranbaxy Laboratories from launching a version of its herpes treatment in the U.S....To view the full article, register now.
Already a subscriber? Click here to view full article